Improving Structure-Based Virtual Screening by Multivariate Analysis of Scoring Data

Journal of Medicinal Chemistry

Volumn 46, Issue 26, 2003, Pages 5781-5789

  Jacobsson, Micael ^a,b   Lidén, Per ^c   Stjernschantz, Eva ^a   Boström, Henrik ^c,d   Norinder, Ulf ^e  

^a Structural Chemistry   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c Österögatan 3 ^*  (Sweden)

^d ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

^e ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; BLOOD CLOTTING FACTOR 10A; ESTROGEN RECEPTOR ALPHA; STROMELYSIN;

ARTICLE; BAYES THEOREM; DISCRIMINANT ANALYSIS; MULTIVARIATE ANALYSIS; PROTEIN TARGETING; SCORING SYSTEM; STATISTICAL ANALYSIS;

ACETYLCHOLINESTERASE; BINDING SITES; ESTROGEN RECEPTOR ALPHA; FACTOR XA; LIGANDS; MATRIX METALLOPROTEINASE 3; MULTIVARIATE ANALYSIS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; RECEPTORS, ESTROGEN;

EID: 0346996357     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm030896t     Document Type: Article

References (43)

1. Halperin, I.; Ma, B.; Wolfson, H.; Nussinov, R. Principles of docking: An overview of search algorithms and a guide to scoring functions. Proteins 2002, 47, 409-443.
2. Sippl, W.; Contreras, J. M.; Parrot, I.; Rival, Y. M.; Wermuth, C. G. Structure-based 3D QSAR and design of novel acetylcholinesterase inhibitors. J. Comput.-Aided Mol. Des. 2001, 15, 395-410.
3. Ha, S.; Andreani, R.; Robbins, A.; Muegge, I. Evaluation of docking/scoring approaches: a comparative study based on MMP3 inhibitors. J. Comput.-Aided Mol. Des. 2000, 14, 435-448.
4. Abagyan, R.; Totrov, M. High-throughput docking for lead generation. Curr. Opin. Chem. Biol. 2001, 5, 375-382.
5. Stahl, M.; Rarey, M. Detailed analysis of scoring functions for virtual screening. J. Med. Chem. 2001, 44, 1035-1042.
6. Schapira, M.; Raaka, B. M.; Samuels, H. H.; Abagyan, R. Rational discovery of novel nuclear hormone receptor antagonists. Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 1008-1013.
7. Filikov, A. V.; Mohan, V.; Vickers, T. A.; Griffey, R. H.; Cook, P. D. et al. Identification of ligands for RNA targets via structure-based virtual screening: HIV-1 TAR. J. Comput.-Aided Mol. Des. 2000, 14, 593-610.
8. Schapira, M.; Totrov, M.; Abagyan, R. Prediction of the binding energy for small molecules, peptides and proteins. J. Mol. Recognit. 1999, 12, 177-190.
9. Åqvist, J.; Marelius, J. The linear interaction energy method for predicting ligand binding free energies. Comb. Chem. High Throughput Screening 2001, 4, 613-626.
10. Bissantz, C.; Folkers, G.; Rognan, D. Protein-based virtual screening of chemical databases. 1. Evaluation of different docking/scoring combinations. J. Med. Chem. 2000, 43, 4759-4767.
11. Charifson, P. S.; Corkery, J. J.; Murcko, M. A.; Walters, W. P. Consensus scoring: A method for obtaining improved hit rates from docking databases of three-dimensional structures into proteins. J. Med. Chem. 1999, 42, 5100-5109.
12. Clark, R. D.; Strizhev, A.; Leonard, J. M.; Blake, J. F.; Matthew, J. B. Consensus scoring for ligand/protein interactions. J. Mol. Graphics Modell. 2002, 20, 281-295.
13. Brzozowski, A. M.; Pike, A. C.; Dauter, Z.; Hubbard, R. E.; Bonn, T.; et al. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 1997, 389, 753-758.
14. Natchus, M. G.; Bookland, R. G.; Laufersweiler, M. J.; Pikul, S.; Almstead, N. G. et al. Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines. J. Med. Chem. 2001, 44, 1060-1071.
15. Kryger, G.; Silman, I.; Sussman, J. L. Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs. Struct. Fold Des. 1999, 7, 297-307.
16. Nar, H.; Bauer, M.; Schmid, A.; Stassen, J. M.; Wienen, W.; et al. Structural basis for inhibition promiscuity of dual specific thrombin and factor Xa blood coagulation inhibitors. Structure (Cambr.) 2001, 9, 29-37.
17. Jones, G.; Willett, P.; Glen, R. C. Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation. J. Mol. Biol. 1995, 245, 43-53.
18. Eldridge, M. D.; Murray, C. W.; Auton, T. R.; Paolini, G. V.; Mee, R. P. Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes. J. Comput.-Aided Mol. Des. 1997, 11, 425-445.
19. Schrödinger FirstDiscovery 2.5 Operating Manual; Schrödinger Press: 2003.
20. Abagyan, R.; Totrov, M. ICM online manual, http://www.mol-soft.com/.
21. Abagyan, R.; Totrov, M. Biased probability Monte Carlo conformational searches and electrostatic calculations for peptides and proteins. J. Mol. Biol. 1994, 235, 983-1002.
22. Wold, S.; Johansson, E.; Cocchi, M. PLS-Partial least-squares projections to latent structures. In 3D QSAR in Drug Design; ESCOM: Leiden, 1993; pp 523-550.
23. Domingos, P.; Pazzani, M. On the optimality of the simple bayesian classifier under zero-one loss. Machine Learning 1997, 29, 103-130.
24. Rule Discovery System (RDS) 0.8, http://www.compumine.com; Compumine AB.
25. Martin, Y. C.; Kofron, J. L.; Traphagen, L. M. Do structurally similar molecules have similar biological activity? J. Med. Chem. 2002, 45, 4350-4358.
26. Wilton, D.; Willet, P. Comparison of Ranking Methods for Virtual Screening in Lead-Discovery Programs. J. Chem. Inf. Comput. Sci. 2003, 43, 469-474.
27. Patel, Y.; Gillet, V. J.; Bravi, G.; Leach, A. R. A comparison of the pharmacophore identification programs: Catalyst, DISCO and GASP. J. Comput.-Aided Mol. Des. 2002, 16, 653-681.
28. Terp, G. E.; Johansen, B. N.; Christensen, I. T.; Jørgensen, F. S. A New Concept for Multidimensional Selection of Ligand Conformations (MultiSelect) and Multidimensional Scoring (MultiScore) of Protein-Ligand Binding Affinities. J. Med. Chem. 2001, 44, 2333-2343.
29. Clark, R. D. OptiSim: An Extended Dissimilarity Selection Method for Finding Diverse Representative Subsets. J. Chem. Inf. Comput. Sci. 1997, 37, 1181-1188.
30. Sadowski, J.; Gasteiger, J. From atoms and bonds to three-dimensional atomic coordinates: Automatic model builders. Chem. Rev. 1993, 93, 2567-2581.
31. Ash, S.; Cline, M. A.; Homer, R. W.; Hurst, T.; Smith, G. B. SYBYL line notation (SLN): A versatile language for chemical structure representation. J. Chem. Inf. Comput. Sci. 1997, 37, 71-79.
32. Muegge, I.; Martin, Y. C. A general and fast scoring function for protein-ligand interactions: a simplified potential approach. J. Med. Chem. 1999, 42, 791-804.
33. Rarey, M.; Kramer, B.; Lengauer, T.; Klebe, G. A fast flexible docking method using an incremental construction algorithm. J. Mol. Biol. 1996, 261, 470-489.
34. Kuntz, I. D.; Blaney, J. M.; Oatley, S. J.; Langridge, R.; Ferrin, T. E. A geometric approach to macromolecule-ligand interactions. J. Mol. Biol. 1982, 161, 269-288.
35. Jones, G.; Willett, P.; Glen, R. C.; Leach, A. R.; Taylor, R. Development and validation of a genetic algorithm for flexible docking. J. Mol. Biol. 1997, 267, 727-748.
36. Quinlan, J. R. Induction of decision trees. Machine Learning 1986, 1, 81-106.
37. Boström, H. Covering vs Divide-and-Conquer for Top-Down Induction of Logic Programs. Fourteenth International Joint Conference on Artificial Intelligence; Morgan Kaufmann: San Mateo, California, 1995; pp 1194-1200.
38. Breiman, L. Bagging Predictors. Machine Learning 1996, 24, 123-140.
39. Wold, S. Cross-validatory estimation of the number of components in factor and principal components models. Technometrics 1979, 20, 379-405.
40. Sippl, W. Receptor-based 3D QSAR analysis of estrogen receptor ligands-merging the accuracy of receptor-based alignments with the computational efficiency of ligand-based methods. J. Comput.-Aided Mol. Des. 2000, 14, 559-572.
41. Shi, L. M.; Fang, H.; Tong, W.; Wu, J.; Perkins, R.; et al. QSAR models using a large diverse set of estrogens. J. Chem. Inf. Comput. Sci. 2001, 41, 186-195.
42. Contreras, J. M.; Parrot, I.; Sippl, W.; Rival, Y. M.; Wermuth, C. G. Design, synthesis, and structure-activity relationships of a series of 3-[2-(1-benzylpiperidin-4-yl)ethylamino]pyridazine derivatives as acetylcholinesterase inhibitors. J. Med. Chem. 2001, 44, 2707-2718.
43. Matter, H.; Defossa, E.; Heinelt, U.; Blohm, P. M.; Schneider, D. et al. Design and quantitative structure-activity relationship of 3-amidinobenzyl-1H-indole-2-carboxamides as potent, non-chiral, and selective inhibitors of blood coagulation factor Xa. J. Med. Chem. 2002, 45, 2749-2769.